JCO Article Insights: Nivolumab + Relatlimab v Nivolumab + Ipilimumab in Melanoma

Information

Show

Journal of Clinical Oncology (JCO) Podcast

Published

November 25, 2024

Type

audio

Language

EN

Author

American Society of Clinical Oncology (ASCO)

Categories

healthfitnessmedicine